NEW YORK BLOOD CENTER, INC
NEW YORK, New York
Total Received
$94.6M
Total Awards
55
State
New York
Last Updated
Mar 30, 2026
Yearly Funding Trend
$60.6M24
$31.8M25
$2.3M26
Top 50 Awards to NEW YORK BLOOD CENTER, INC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 30, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P01HL149626_075 COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY - OUR PROGRAM PROJECT FOCUSES ON MECHANISTIC UNDERSTANDING OF THE BENEFICIAL AND HARMFUL EFFECTS OF RED BLOOD CELL (RBC) TRANSFU… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $18,556,003 |
ASST_NON_P01DK032094_075 RED CELL MEMBRANE STUDIES - OVERALL PROJECT ABSTRACT ANEMIA IS A MAJOR HEALTH PROBLEM AFFECTING MILLIONS OF INDIVIDUALS AROUND THE WORLD. THE OVERALL OBJECTIVE OF THE PROPOSED PRO… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | NEW YORK, NY-12 | 2025 | $14,294,818 |
CONT_AWD_HHSH250201000010C_7526_-NONE-_-NONE- NYBC - COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH QUALITY UMBILICAL CORD BLOOD UNITS | Department of Health and Human Services Health Resources and Services Administration | — | NEW YORK, NY-12 | 2025 | $12,313,923 |
ASST_NON_R01AI104416_075 DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 - PROJECT SUMMARY/ABSTRACT THE HIV-1 ENVELOPE GLYCOPROTEIN GP120 PLAYS A CRITICAL ROLE IN MEDIATING VIRAL ENT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $7,935,599 |
ASST_NON_R01AI078314_075 THE DEVELOPMENT OF A RECOMBINANT VACCINE AGAINST HUMAN ONCHOCERCIASIS - ABSTRACT HUMAN ONCHOCERCIASIS (ONCHO) IS A MAJOR CAUSE OF INFECTIOUS BLINDNESS, SKIN DISEASE, AND CHRONIC D… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $6,968,594 |
ASST_NON_R35HL161239_075 IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTING FROM ONGOING HEMO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | RYE, NY-16 | 2024 | $4,491,668 |
ASST_NON_U01AI160421_075 RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN THE E… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $3,749,095 |
ASST_NON_R01HL124015_075 LATEXIN FUNCTION IN THE MAINTENANCE AND REGENERATION OF THE HEMATOPOIETIC SYSTEM - ABSTRACT THE HEMATOPOIETIC SYSTEM IS VERY SENSITIVE TO A VARIETY OF STRESSES. RADIATION THERAPY… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $3,598,058 |
ASST_NON_R01MH118960_075 NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC - ABSTRACT MARKED DISPARITIES BY RACE/ETHNICITY EXIST IN HIV INFECTION RATES AND ENGAGEMENT AND… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | NEW YORK, NY-12 | 2024 | $3,539,511 |
ASST_NON_R01HL155574_075 HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHROCYTES), IMMUNE CELL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $2,466,695 |
ASST_NON_R01HL165202_075 TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DISEASE (SCD). HOWEVER… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $2,430,867 |
ASST_NON_R61AI187095_075 DESIGNING A ROBUST PLATFORM FOR THE IN VITRO PROPAGATION OF BABESIA MICROTI IN HUMAN RBCS - THE OVERALL GOAL OF THE R61 PHASE OF OUR PROPOSAL IS TO ESTABLISH A CONTINUOUS IN VITRO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | RYE, NY-16 | 2025 | $854,000 |
ASST_NON_R56HL165202_075 TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DISEASE (SCD). HOWEVER… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $803,749 |
ASST_NON_R01HL181370_075 ERYTHROBLASTIC ISLAND MACROPHAGES IN NORMAL ERYTHROPOIESIS AND DISORDERED ERYTHROPOIESIS IN POLYCYTHEMIA VERA - ABSTRACT ERYTHROPOIESIS OCCURS AT THE ERYTHROBLASTIC ISLAND WHERE T… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | NEW YORK, NY-12 | 2025 | $801,628 |
ASST_NON_R56AI104416_075 DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV - 1GP120 - PROJECT SUMMARY/ABSTRACT THE HIV-1 ENVELOPE GLYCOPROTEIN (ENV) GP120 IS CRITICAL IN MEDIATING VIRAL ENTRY… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $777,088 |
ASST_NON_R21AR079766_075 AUTOPHAGIC REGULATION OF INFLAMMASOME-MEDIATED HYPERACTIVE STATE IN LIVING MACROPHAGES - ABSTRACT NUCLEOTIDE-BINDING DOMAIN (NBD) AND LEUCINE-RICH REPEAT (LRR)-CONTAINING PROTEINS… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $675,351 |
CONT_AWD_36C24226N0095_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $650,000 |
CONT_AWD_36C24226N0067_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $637,500 |
CONT_AWD_36C24223N0107_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $636,000 |
ASST_NON_R21AI153649_075 ACTIVATING AUTOPHAGY IN FILARIAL WORMS TO IDENTIFY NOVEL MACROFILARICIDES - MORE THAN 120 MILLION OF POOREST IN THE WORLD ARE AT HIGH RISK OF SUFFERING THE DEBILITATING EFFECTS OF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2024 | $496,596 |
ASST_NON_R21MH124474_075 A SEQUENTIAL MIXED METHODS STUDY EVALUATING THE INFLUENCE OF VIOLENCE ON HIV CARE AND VIRAL SUPPRESSION AMONG YOUNG BLACK AND LATINX MSM - ABSTRACT VIRAL SUPPRESSION IS CRITICAL… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | NEW YORK, NY-12 | 2024 | $490,382 |
ASST_NON_R21MH136915_075 IMPACT OF GEOGRAPHIC MOBILITY ON PRE-EXPOSURE PROPHYLAXIS AND HIV CARE OUTCOMES - HIV CONTINUES TO BE A MAJOR PUBLIC HEALTH CONCERN FOR MEN WHO HAVE SEX WITH MEN IN THE U.S. MEN W… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | NEW YORK, NY-12 | 2024 | $486,009 |
ASST_NON_R21MH140665_075 INFLUENCE OF SOCIAL NETWORKS ON HIV TESTING AND PREP CARE AMONG YOUNG LATIN AMERICAN GAY, BISEXUAL, AND OTHER MEN WHO HAVE SEX WITH MEN - HIV CONTINUES TO BE A MAJOR, “INVISIBLE”… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | NEW YORK, NY-12 | 2025 | $485,131 |
CONT_AWD_36C24223N0105_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $443,968 |
CONT_AWD_75R60219C00008_7526_-NONE-_-NONE- NATIONAL CORD BLOOD INVENTORY | Department of Health and Human Services Health Resources and Services Administration | — | NEW YORK, NY-12 | 2025 | $435,700 |
CONT_AWD_36C24224N0093_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $405,490 |
CONT_AWD_36C24222N0132_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $401,294 |
CONT_AWD_36C24225N0415_3600_36C24225D0050_3600 NYBC VISN 2 BLOOD PRODCUTS AND SUPPLIES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $400,000 |
CONT_AWD_36C24224N0095_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $326,077 |
CONT_AWD_36C24226N0099_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $319,941 |
CONT_AWD_36C24225N0143_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $303,750 |
CONT_AWD_36C24225N0431_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $277,321 |
ASST_NON_K99AI182422_075 STRUCTURAL AND FUNCTIONAL ALTERATION OF HOST RBCS BY BABESIA - BABESIA SPP., THE ETIOLOGIC AGENTS OF BABESIOSIS IN ANIMALS AND HUMANS, ARE INTRAERYTHROCYTIC PROTOZOAN PARASITES TR… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | RYE, NY-16 | 2025 | $269,460 |
ASST_NON_R21AI183544_075 EFFECTS OF EXOGENOUS HORMONE TREATMENT ON VACCINE RESPONSES - ABSTRACT: SEX DIFFERENCES IN IMMUNITY ARE DYNAMIC THROUGHOUT THE LIFESPAN AND CONTRIBUTE TO HETEROGENEITY IN RISK OF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-12 | 2025 | $267,121 |
ASST_NON_R21HL175096_075 EVALUATING ACCESSORY CELLS TO IMPROVE HOMING AND ENGRAFTMENT EFFICIENCY OF CD34+ CELLS FROM SICKLE CELL DISEASE PATIENTS - AS A CURE FOR THE LIFE-THREATENING HEMOGLOBINOPATHY OF S… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | RYE, NY-16 | 2024 | $256,200 |
CONT_AWD_36C24224N0094_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $217,694 |
CONT_AWD_36C24224N0096_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $208,420 |
CONT_AWD_36C24225N0144_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $200,000 |
CONT_AWD_36C24226N0098_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $196,743 |
CONT_AWD_36C24220N0309_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $192,513 |
CONT_AWD_36C24225N0424_3600_36C24225D0050_3600 BRONX-BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $183,133 |
CONT_AWD_36C24223N0109_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $180,083 |
CONT_AWD_36C24225N0145_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $177,975 |
ASST_NON_R21AI193881_075 DEVELOPMENT OF A RADIATION COUNTERMEASURE WITH SEX-DEPENDENT RADIATION RESPONSE. - PROJECT SUMMARY/ABSTRACT THE RESEARCH GOAL IS TO UNDERSTAND THE MECHANISM UNDERLYING SEX-SPECIFI… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | NEW YORK, NY-12 | 2025 | $170,800 |
CONT_AWD_36C24225N0422_3600_36C24225D0050_3600 NORTHPORT VA BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $153,075 |
CONT_AWD_36C24223N0106_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $128,454 |
CONT_AWD_36C24225N0146_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2025 | $90,079 |
CONT_AWD_36C24226N0097_3600_36C24225D0050_3600 BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2026 | $75,000 |
CONT_AWD_36C24223N0108_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $61,303 |
CONT_AWD_36C24224N0097_3600_36C24220D0023_3600 BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | Department of Veterans Affairs Department of Veterans Affairs | — | NEW YORK, NY-12 | 2024 | $53,382 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→Federal Programs (CFDA)
View All→123456
93.837 — CARDIOVASCULAR DISEASES RESEARCH$33.4M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$21.3M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$14.3M
93.242 — MENTAL HEALTH RESEARCH GRANTS$5.0M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$675K
93.310 — TRANS-NIH RESEARCH SUPPORT$171K
Source: USAspending.gov · All Recipients · New York